Ginzburg announced the deadline for receiving the Soviet cancer vaccine

Within a few months, the first patients will be able to undergo treatment with a domestic personalized cancer vaccine. This was announced on August 3 by Alexander Gintsburg, Director of the N. F. Gamalei National Research Center for Epidemiology and Microbiology (NITSEM).

"According to the existing plan agreed with the Ministry of Health, we should begin experimentally administering a cancer vaccine <...> to a group of cancer patients with melanoma in the coming months," he said in an interview with RIA Novosti.

He clarified that NICEM is solely responsible for the production of the vaccine. The finished vaccine will be sent to the Herzen Institute and the Blokhin Oncology Center.

"The regulation of this drug <...> is fundamentally different from that of all other drugs," Ginzburg shared.

The specialist noted that the new vaccine is already attracting international interest.

Traces of blood: Russia has created software for early cancer diagnosis

The program has already been registered and can be used in medical institutions.

On August 1, Evgeny Libson, Deputy Director of the Institute of Oncology at the European Medical Center (EMC), spoke about the importance of early detection of lung cancer. Libson noted that low-dose computed tomography (CT) is an effective method of detecting the disease.

All important news is on the Izvestia channel in the MAX messenger.